- Home
- MDXH vs DTF Comparison
MDXH vs DTF Comparison
Compare MDXH & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- DTF
- Stock Information
- Founded
- MDXH 2003
- DTF 1991
- Country
- MDXH Belgium
- DTF United States
- Employees
- MDXH N/A
- DTF N/A
- Industry
- MDXH
- DTF Investment Managers
- Sector
- MDXH
- DTF Finance
- Exchange
- MDXH Nasdaq
- DTF Nasdaq
- Market Cap
- MDXH 93.1M
- DTF 79.4M
- IPO Year
- MDXH 2021
- DTF N/A
- Fundamental
- Price
- MDXH $2.00
- DTF $11.24
- Analyst Decision
- MDXH Strong Buy
- DTF
- Analyst Count
- MDXH 2
- DTF 0
- Target Price
- MDXH $7.00
- DTF N/A
- AVG Volume (30 Days)
- MDXH 136.8K
- DTF 21.1K
- Earning Date
- MDXH 02-26-2025
- DTF 01-01-0001
- Dividend Yield
- MDXH N/A
- DTF 3.64%
- EPS Growth
- MDXH N/A
- DTF N/A
- EPS
- MDXH N/A
- DTF 0.44
- Revenue
- MDXH $84,708,000.00
- DTF N/A
- Revenue This Year
- MDXH $27.57
- DTF N/A
- Revenue Next Year
- MDXH $20.09
- DTF N/A
- P/E Ratio
- MDXH N/A
- DTF $24.34
- Revenue Growth
- MDXH 33.01
- DTF N/A
- 52 Week Low
- MDXH $1.55
- DTF $10.29
- 52 Week High
- MDXH $4.44
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- MDXH 40.19
- DTF 53.47
- Support Level
- MDXH $1.96
- DTF $11.13
- Resistance Level
- MDXH $2.25
- DTF $11.30
- Average True Range (ATR)
- MDXH 0.18
- DTF 0.07
- MACD
- MDXH -0.05
- DTF 0.01
- Stochastic Oscillator
- MDXH 5.71
- DTF 87.28
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.